The role of contrast enhanced spectral mammography in monitoring the response to neoadjuvant chemotherapy /
Sherihan Mahmoud Saad
The role of contrast enhanced spectral mammography in monitoring the response to neoadjuvant chemotherapy / دور التصوير بالأشعة الرقمية للثدى بالصبغة فى مراقبة الاستجابة للعلاج الكيميائى المساعد Sherihan Mahmoud Saad ; Supervised Rasha Kamal , Omnia Mokhtar , Mohamed Mohamed Gomaa - Cairo : Sherihan Mahmoud Saad , 2017 - 83 P. : facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Radio-diagnosis
Breast cancer is the most common cancer in women. Neoadjuvant chemotherapy (NAC); is the administration of chemotherapy to treat invasive breast cancer before surgery. The accurate assessment of residual tumor after NAC is a crucial prognostic factor for determining outcome and likely survival of the patient. The ability to distinguish between responsive and non-responsive patients is of critical importance for making treatment choices. Contrast enhanced spectral mammography (CESM) is an emerging modality currently under evaluation to determine its accuracy in the assessment of residual tumor after NAC
Breast cancer Neoadjuvant chemotherapy Response monitoring
The role of contrast enhanced spectral mammography in monitoring the response to neoadjuvant chemotherapy / دور التصوير بالأشعة الرقمية للثدى بالصبغة فى مراقبة الاستجابة للعلاج الكيميائى المساعد Sherihan Mahmoud Saad ; Supervised Rasha Kamal , Omnia Mokhtar , Mohamed Mohamed Gomaa - Cairo : Sherihan Mahmoud Saad , 2017 - 83 P. : facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Radio-diagnosis
Breast cancer is the most common cancer in women. Neoadjuvant chemotherapy (NAC); is the administration of chemotherapy to treat invasive breast cancer before surgery. The accurate assessment of residual tumor after NAC is a crucial prognostic factor for determining outcome and likely survival of the patient. The ability to distinguish between responsive and non-responsive patients is of critical importance for making treatment choices. Contrast enhanced spectral mammography (CESM) is an emerging modality currently under evaluation to determine its accuracy in the assessment of residual tumor after NAC
Breast cancer Neoadjuvant chemotherapy Response monitoring